Calcium Acetate
Back to searchMolecule Structure
Scientific Name
Calcium Acetate
Description of the Drug
Calcium acetate is a phosphate binder used in patients with end-stage renal disease (ESRD) to prevent elevated phosphate levels and resulting ectopic calcification and secondary hyperparathyroidism.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00258
http://www.drugbank.ca/drugs/DB00258
Brand Name(s)
Calcium acetate, Eliphos, Everose, Phosex, Phoslo, Phoslo gelcaps, Phoslyra, Renacet
Company Owner(s)
Nostrum Laboratories Inc, Lotus Pharmaceutical Co Ltd Nantou Plant, Padagis Us Llc, Fresenius Medical Care North America, Invagen Pharmaceuticals Inc, Chartwell Molecular Holdings Llc, Heritage Pharmaceuticals Inc, Chartwell Rx Sciences Llc, Cypress Pharmaceutical Inc, Suven Pharmaceuticals Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Phosphate | SMALL MOLECULE | SEQUESTERING AGENT | CHEMBL2364184 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL23872 | |||
| PharmGKB | PA164746897 | |||
| Human Metabolome Database | HMDB0303554 | |||
| DrugBank | DB00258 | |||
| PubChem: Thomson Pharma | 15339446 | 16105670 | ||
| PubChem | 6116 | 517040 | ||
| Nikkaji | J4.823B | |||
| EPA CompTox Dashboard | DTXSID0020234 | |||
| Brenda | 105634 | |||
| ChemicalBook | CB8312095 | |||
| rxnorm | PHOSLYRA | CALCIUM ACETATE | PHOSLO | ELIPHOS |
| ChEBI | 3310 |
